Exdensur (depemokimab) approved in Japan for severe asthma and chronic rhinosinusitis with nasal pol

Exdensur (depemokimab) approved in Japan for severe asthma and chronic rhinosinusitis with nasal polyps

Exdensur is the first and only ultra-long-acting biologic in Japan for the treatment of severe asthma and CRSwNP